Indegene in the news

Commercial

Indegene Receives Frost & Sullivan's 2026 Global Enabling Technology Leadership Recognition for AI-Powered Pharma Commercialization

Commercial & Digital Transformation

Rethinking Mature Brands: Lessons from Pfizer's Innovation Playbook

Technology, Digital Transformation & Analytics

From 8 Weeks to 5 Days: Vertex's AI-Powered Operating Model Shift

Analytics

From Promise to Performance: Life Sciences Leaders Focus on Operationalizing AI to Deliver Enterprise Outcomes at Indegene Digital Summit 2026

Commercial

Indegene Identified as a Leader in ISG Provider Lens™ for Life Sciences Digital Services in Commercial Operations – Digital Evolution (Service Providers) Quadrant 2026

Corporate

Life Sciences Leader Jill DeSimone and Private Equity Executive Neeraj Bharadwaj Join Indegene’s Board

Medical Affairs

A New Era of Medical Affairs–Commercial Collaboration

Analytics

PharmaVoice's Crystal Ball: What's next for AI and drug R&D

Medical Affairs

Compliance and Creativity Converge as MLR Reframes Modern Medical Content

Clinical

Tokenization and Real-World Data Linkage: A New Era in Patient-Centric Trials

Regulatory Affairs

Indegene Exec On R&D Operations In The Age Of GenAI, One Click Submissions

Regulatory Affairs

How Big Pharma is Rethinking Regulatory Operations in the Digital Era